Akzo Nobel's Diosynth Biotechnology and Human Genome Sciences sign antibody manufacturing agreement
Akzo Nobel's Diosynth Biotechnology and Human Genome Sciences sign antibody manufacturing agreement Arnhem / Oss, the Netherlands, June 10, 2004 - Akzo Nobel's Diosynth Biotechnology business and Human Genome Sciences, Inc. (HGSI) have reached an agreement on the process development and production of clinical quantities of a therapeutic monoclonal antibody. Under the agreement, Diosynth Biotechnology will be responsible for technology transfer, scaling-up and production in Diosynth's new large-scale cell culture facility in Oss, the Netherlands. Financial terms of the agreement were not